Immediate Impact
56 standout
Citing Papers
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
2024 Standout
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
2024 Standout
Works of ZoAnn E. Dreyer being referenced
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631
2021
Nonmelanoma Skin Cancer in Survivors of Childhood and Adolescent Cancer: A Report From the Childhood Cancer Survivor Study
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| ZoAnn E. Dreyer | 132 | 131 | 36 | 55 | 8 | 265 | |
| FrederickP. Li | 101 | 72 | 26 | 64 | 9 | 228 | |
| Maxine Hetherington | 69 | 43 | 28 | 45 | 15 | 271 | |
| A. M. Rauck | 82 | 128 | 21 | 54 | 9 | 306 | |
| Sharon Bergeron | 141 | 79 | 36 | 69 | 10 | 278 | |
| PG Dyment | 196 | 127 | 71 | 66 | 11 | 329 | |
| Aiko Kida | 61 | 53 | 37 | 71 | 12 | 285 | |
| Pui Ch | 214 | 145 | 24 | 27 | 7 | 297 | |
| Jean-Marie Leclerc | 42 | 81 | 9 | 46 | 6 | 262 | |
| S Mills | 60 | 33 | 38 | 85 | 7 | 263 | |
| Bruce Greig | 92 | 19 | 72 | 82 | 10 | 306 |
All Works
Loading papers...